Silverarc Capital Management, LLC Biogen Inc. Transaction History

Silverarc Capital Management, LLC

$353 Million
Q2 2024

A detailed history of Silverarc Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 19,365 shares of BIIB stock, worth $3.37 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

19,365

Previous 19,365 -0.0%

Holding current value

$3.37 Million

Previous $4.18 Million 7.52%

% of portfolio

1.27%

Previous 1.4%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $134,632 - $169,995	-635 Reduced 3.18%	19,365 $4.18 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $1.8 Million - $2.16 Million	-8,069 Reduced 28.75%	20,000 $5.18 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $307,759 - $347,356	1,215 Added 4.52%	28,069 $7.21 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $4.28 Million - $4.94 Million	15,543 Added 137.41%	26,854 $7.65 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $2.74 Million - $3.12 Million	-10,664 Reduced 48.53%	11,311 $3.14 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $5.55 Million - $6.74 Million	21,975 New	21,975 $6.09 Million
Q2 2022 Jul 25, 2022	BUY	$187.54 - $223.02 $1.98 Million - $2.36 Million	10,577 Added 103.21%	20,825 $4.25 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $872,740 - $1.1 Million	4,504 Added 78.41%	10,248 $230,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $303,411 - $389,928	1,355 Added 30.87%	5,744 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.24 Million - $1.62 Million	4,389 New	4,389 $1.24 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $1.3 Million - $2.07 Million	-5,000 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$242.95 - $284.63 $485,900 - $569,260	2,000 Added 66.67%	5,000 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $708,780 - $1.07 Million	3,000 New	3,000 $735,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Biogen Inc. Transaction History